4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-005617
CVP, EMEACLA and JAPAC sold 6,640 shares at $88.68 ($588,835)
- CVP, EMEACLA and JAPAC acquired 9,995 shares (option exercise)
- CVP, EMEACLA and JAPAC gave up 328 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lemercier Jean-Luc M · CVP, EMEACLA and JAPAC
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,355 | 172,417.78 | D | ||
| 2023-05-07 | Shares withheld for taxes : show line 2 in the form 10b5-1 | −224 | $88.74 | $19,878 | 172,193.78 | D |
| 2023-05-08 | Shares withheld for taxes : show line 3 in the form 10b5-1 | −104 | $88.74 | $9,229 | 172,089.78 | D |
| 2023-05-09 | Exercise or conversion : show line 4 in the form 10b5-1 | +6,640 | $35.20 | $233,706 | 178,729.78 | D |
| 2023-05-09 | Sale : show line 5 in the form 10b5-1 | −6,640 | $88.68 | $588,835 | 172,089.78 | D |
| Open-market sales · 6,640 sh · avg $88.68 · $588,835 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-05-07 | Exercise or conversion : show line 6 in the form 10b5-1 Performance Rights | −3,355 | 2027-05-06 | 3,355 | 920 | D | |
| 2023-05-09 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −6,640 | $35.20 | 2023-05-11 | 6,640 | 0 | D |
Loading xslF345X04/doc4.xml…